Impact of Epithelial–Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ

The biology and function of fibroblasts in cancer

Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366 · see citing works

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · see citing works

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590 · see citing works

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085 · see citing works

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer

Cox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569 · see citing works

GAGE: generally applicable gene set enrichment for pathway analysis

Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D., & Woolf, P. J. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-161 · Cited by 1,333 · see citing works

Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5

Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., & Quaranta, V. (1997) · Science · doi:10.1126/science.277.5323.225 · Cited by 1,221 · see citing works

The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis

McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966 · see citing works

Rosen's Breast Pathology

Rosen, P. P. (1997) · Cited by 820 · see citing works

Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways

Boelens, M., Wu, T. J., Nabet, B., Xu, B.-H., Qiu, Y., Yoon, T., Azzam, D. J., Victor, C. T.-S., Wiemann, B., Ishwaran, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.051 · Cited by 768 · see citing works

Gene expression profiling of the tumor microenvironment during breast cancer progression

Ma, X., Dahiya, S. M., Richardson, E., Erlander, M. G., & Sgroi, D. C. (2009) · Breast Cancer Research · doi:10.1186/bcr2222 · Cited by 618 · see citing works

Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes

Virnig, B. A., Tuttle, T. M., Shamliyan, T., & Kane, R. L. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp482 · Cited by 610 · see citing works

LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis

Cox, T. R., Bird, D., Baker, A.-M., Barker, H. E., Ho, M. W.-Y., Lang, G., & Erler, J. T. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2233 · Cited by 571 · see citing works

Cancer-associated fibroblasts and tumor growth – bystanders turning into key players

Östman, A., & Augsten, M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.003 · Cited by 542 · see citing works

Rosen's Breast Pathology

Grases, P. J. (2002) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(02)75784-1 · Cited by 499 · see citing works

Regulation of In Situ to Invasive Breast Carcinoma Transition

Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D. R., Richardson, A. L., Violette, S. M., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 497 · see citing works

Therapeutic modulation of Notch signalling — are we there yet?

Andersson, E. R., & Lendahl, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4252 · Cited by 452 · see citing works

Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.

Pietras, K., Rubin, K., Sjöblom, T., Buchdunger, E., Sjöquist, M., Heldin, C., & Östman, A. (2002) · PubMed · Cited by 432 · see citing works

New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes

Sheldon, H., Heikamp, E., Turley, H., Dragovic, R., Thomas, P. H., Oon, C. E., Leek, R., Edelmann, M. J., Kessler, B. M., Sainson, R. C. A., et al. (2010) · Blood · doi:10.1182/blood-2009-08-239228 · Cited by 409 · see citing works

NOTCH3 Expression Is Induced in Mural Cells Through an Autoregulatory Loop That Requires Endothelial-Expressed JAGGED1

Liu, H., Kennard, S., & Lilly, B. (2009) · Circulation Research · doi:10.1161/circresaha.108.184846 · Cited by 286 · see citing works

Dynamic Filopodia Transmit Intermittent Delta-Notch Signaling to Drive Pattern Refinement during Lateral Inhibition

Cohen, M., Γεωργίου, Μ., Stevenson, N. L., Miodownik, M. A., & Baum, B. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.006 · Cited by 272 · see citing works

Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin.

Albrechtsen, R., Nielsen, M., Wewer, U. M., Engvall, E., & Ruoslahti, E. I. (1981) · PubMed · Cited by 269 · see citing works

Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer

Paulsson, J., Sjöblom, T., Micke, P., Pontén, F., Landberg, G., Heldin, C., Bergh, J. C. S., Brennan, D. J., Jirström, K., & Östman, A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081030 · Cited by 267 · see citing works

Fibroblasts as architects of cancer pathogenesis

Marsh, T., Pietras, K., & McAllister, S. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.013 · Cited by 263 · see citing works

Progression from ductal carcinoma in situ to invasive breast cancer: Revisited

Cowell, C. F., Weigelt, B., Sakr, R. A., Ng, C. K. Y., Hicks, J. B., King, T. A., & Reis-Filho, J. S. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.07.005 · Cited by 259 · see citing works

Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition

del Alcazar, C. R. G., Huh, S. J., Ekram, M. B., Trinh, A. C., Liu, L. L., de Beça, F. F., Zi, X., Kwak, M., Bergholtz, H., Su, Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0222 · Cited by 249 · see citing works

Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation

Procopio, M.-G., Laszlo, C., Al Labban, D., Kim, D. E., Bordignon, P., Jo, S.-H., Goruppi, S., Menietti, E., Ostano, P., Ala, U., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3228 · Cited by 223 · see citing works

Role of COX-2 in epithelial–stromal cell interactions and progression of ductal carcinoma in situ of the breast

Hu, M. S., Peluffo, G., Chen, H., Gelman, R. S., Schnitt, S. J., & Polyák, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813306106 · Cited by 205 · see citing works

Platelet-Derived Growth Factor Production by B16 Melanoma Cells Leads to Increased Pericyte Abundance in Tumors and an Associated Increase in Tumor Growth Rate

Furuhashi, M., Sjöblom, T., Abramsson, A., Ellingsen, J., Micke, P., Li, H., Folestad, E. B., Eriksson, U., Heuchel, R. L., Betsholtz, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1489 · Cited by 204 · see citing works

Notch Signaling Regulates Platelet-Derived Growth Factor Receptor-β Expression in Vascular Smooth Muscle Cells

Jin, S., Hansson, E. M., Tikka, S., Lanner, F., Sahlgren, C., Farnebo, F. A., Baumann, M., Kalimo, H., & Lendahl, U. (2008) · Circulation Research · doi:10.1161/circresaha.107.167965 · Cited by 197 · see citing works

STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer

Peña, C., Céspedes, M. V., Lindh, M. B., Kiflemariam, S., Mezheyeuski, A., Edqvist, P.-H. D., Hägglöf, C., Birgisson, H., Bojmar, L., Jirström, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1875 · Cited by 182 · see citing works

Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis

Heldin, C. ‐., Lennartsson, J., & Westermark, B. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12690 · Cited by 181 · see citing works

Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in Cancer

Previs, R. A., Coleman, R. L., Harris, A. L., & Sood, A. K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0809 · Cited by 173 · see citing works

Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast

Vincent‐Salomon, A., Lucchesi, C., Gruel, N., Raynal, V., Pierron, G., Goudefroye, R., Reyal, F., Radvanyi, F., Salmon, R. J., Thiery, J. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1465 · Cited by 156 · see citing works

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling

Roswall, P., Bocci, M., Bartoschek, M., Li, H., Kristiansen, G., Jansson, S., Lehn, S., Sjölund, J., Reid, S., Larsson, C., et al. (2018) · Nature Medicine · doi:10.1038/nm.4494 · Cited by 150 · see citing works

Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer

Witkiewicz, A. K., Dasgupta, A., Nguyen, K., Liu, C., Kovatich, A. J., Schwartz, G. F., Pestell, R. G., Sotgia, F., Rui, H., & Lisanti, M. P. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.11.8874 · Cited by 128 · see citing works

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)

Gabrielson, M., Eriksson, M., Hammarström, M., Borgquist, S., Leifland, K., Czene, K., & Hall, P. N. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw357 · Cited by 123 · see citing works

Wide Distribution of Laminin-5 γ2 Chain in Basement Membranes of Various Human Tissues

Mizushima, H., Koshikawa, N., Moriyama, K., Takamura, H., Nagashima, Y., Hirahara, F., & Miyazaki, K. (1998) · Hormone Research in Paediatrics · doi:10.1159/000053118 · Cited by 111 · see citing works

Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival

Hägglöf, C., Hammarsten, P., Josefsson, A., Stattin, P. E., Paulsson, J., Bergh, A. R. J., & Östman, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010747 · Cited by 109 · see citing works

Distinct Effects of Ligand-Induced PDGFRα and PDGFRβ Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments

Ehnman, M., Missiaglia, E., Folestad, E. B., Selfe, J., Strell, C., Thway, K., Brodin, B. A., Pietras, K., SHIPLEY, J. M., Östman, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1646 · Cited by 98 · see citing works

Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity

Funahashi, Y., Shawber, C. J., Sharma, A., Kanamaru, E., Choi, Y. K., & Kitajewski, J. (2011) · Vascular Cell · doi:10.1186/2045-824x-3-2 · Cited by 91 · see citing works

PDGF receptors in tumor stroma: Biological effects and associations with prognosis and response to treatment

Östman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.022 · Cited by 90 · see citing works

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence

Jansson, S., Aaltonen, K. E., Bendahl, P., Falck, A., Karlsson, M. E., Pietras, K., & Rydén, L. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4664-7 · Cited by 88 · see citing works

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence

Nordby, Y., Richardsen, E. H., Rakaee, M., Ness, N., Dønnem, T., Patel, H., Busund, L., Bremnes, R. M., & Andersen, S. (2017) · Scientific Reports · doi:10.1038/srep43378 · Cited by 76 · see citing works

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

Johnson, C. E., Gorringe, K. L., Thompson, E. R., Opeskin, K., Boyle, S. E., Wang, Y.-K., Hill, P., Mann, G. B., & Campbell, I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1835-1 · Cited by 67 · see citing works

Second events following ductal carcinoma in situ of the breast: a register-based cohort study

Falk, R. S., Hofvind, S. S. H., Skaane, P., & Haldorsen, T. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1531-1 · Cited by 56 · see citing works

Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions

Gargano, S., Bombonati, A., & Palazzo, J. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.11.003 · Cited by 55 · see citing works

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival

Corvigno, S., Wisman, G. B. A., Mezheyeuski, A., van der Zee, A. G. J., Nijman, H. W., Åvall-Lundqvist, E. H., Östman, A., & Dahlstrand, H. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7613 · Cited by 46 · see citing works

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

Paulsson, J., Rydén, L., Strell, C., Frings, O., Tobin, N. P., Fornander, T., Bergh, J. C. S., Landberg, G., Stål, O., & Östman, A. (2016) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.56 · Cited by 43 · see citing works

Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma

Martins, D. F., de Beça, F. F., Sousa, B., Baltazar, F., Paredes, J., & Schmitt, F. C. (2013) · Cell Cycle · doi:10.4161/cc.25794 · Cited by 42 · see citing works

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study

Zhou, W., Jirström, K., Johansson, C., Amini, R., BLOMQVIST, C. P., Agbaje, O. F., & Wärnberg, F. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-653 · Cited by 41 · see citing works

Involvement of the notch pathway in the regulation of matrix metalloproteinase 13 and the dedifferentiation of articular chondrocytes in murine cartilage

Blaise, R., Mahjoub, M., Salvat, C., Barbe, U., Brou, C., Corvol, M. T., Savouret, J., Rannou, F., Berenbaum, F., & Bausero, P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24250 · Cited by 39 · see citing works

Identifying progression predictors of breast ductal carcinoma in situ

Yeong, J. P.-S., Thike, A. A., Tan, P. H., & Iqbal, J. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-204154 · Cited by 36 · see citing works

Loss of CSL Unlocks a Hypoxic Response and Enhanced Tumor Growth Potential in Breast Cancer Cells

Braune, E.-B., Tsoi, Y. L., Phoon, Y. P., Landor, S. K.-J., Cascales, H. S., Ramsköld, D., Deng, Q., Lindqvist, A., Lian, X. L., Sahlgren, C., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.03.004 · Cited by 35 · see citing works

Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events

Karlsson, E., Sandelin, K., Appelgren, J., Zhou, W., Jirström, K., Bergh, J. C. S., & Wärnberg, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.10.020 · Cited by 29 · see citing works

A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years

Wadsten, C., Heyman, H., Holmqvist, M., Ahlgren, J., Lambe, M. P., Sund, M., & Wärnberg, F. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1211317 · Cited by 21 · see citing works

A Comparison of Tumor Biology in Primary Ductal CarcinomaIn SituRecurring as Invasive Carcinoma versus a NewIn Situ

Zhou, W., Johansson, C., Jirström, K., Ringberg, A., BLOMQVIST, C. P., Amini, R., Fjällskog, M.-L., & Wärnberg, F. (2013) · International Journal of Breast Cancer · doi:10.1155/2013/582134 · Cited by 19 · see citing works

A contribution to the natural history of breast cancer

Tulusan, A. H., Grünsteidel, W., Ramming, I., & Egger, H. (1982) · Archives of Gynecology and Obstetrics · doi:10.1007/bf02110120 · Cited by 16 · see citing works

A Quantitative Study of Patterns of Basement Membrane in Ductal Carcinoma In Situ (DCIS) of the Breast

Rajan, P. B., & Perry, R. H. (1995) · The Breast Journal · doi:10.1111/j.1524-4741.1995.tb00255.x · Cited by 3 · see citing works

A framework for advancing our understanding of cancer-associated fibroblasts

Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · see citing works

Notch signaling pathway: architecture, disease, and therapeutics

Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,145 · see citing works

Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.

Kieffer, Y., Hocine, H. R., Gentric, G., Pelon, F., Bernard, C., Bourachot, B., Lameiras, S., Albergante, L., Bonneau, C., Guyard, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1384 · Cited by 910 · see citing works

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 440 · see citing works

Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms

Pelon, F., Bourachot, B., Kieffer, Y., Magagna, I., Mermet‐Meillon, F., Bonnet, I., Costa, A., Givel, A.-M., Atieh, Y., Barbazán, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14134-w · Cited by 392 · see citing works

Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities

Hu, D., Li, Z., Zheng, B., Lin, X., Pan, Y., Gong, P., Zhuo, W., Hu, Y., Chen, C., Chen, L., et al. (2022) · 癌症：英文版 · doi:10.1002/cac2.12291 · Cited by 293 · see citing works

Targeting Notch in oncology: the path forward

Majumder, S., Crabtree, J. S., Golde, T. E., Minter, L. M., Osborne, B. A., & Miele, L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00091-3 · Cited by 274 · see citing works

Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies

Mhaidly, R., & Mechta‐Grigoriou, F. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101417 · Cited by 258 · see citing works

Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer

Mhaidly, R., & Mechta‐Grigoriou, F. (2021) · Immunological Reviews · doi:10.1111/imr.12978 · Cited by 231 · see citing works

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

Liu, Y., Sinjab, A. F., Min, J., Han, G., Paradiso, F., Zhang, Y., Wang, R., Pei, G., Dai, Y., Liu, Y., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.004 · Cited by 249 · see citing works

Epithelial cells activate fibroblasts to promote esophageal cancer development

Chen, Y., Zhu, S., Liu, T., Zhang, S., Lu, J., Fan, W., Lin, L., Xiang, T., Yang, J., Zhao, X., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.03.001 · Cited by 207 · see citing works

Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression

Primac, I., Maquoi, E., Blacher, S., Heljäsvaara, R., Deun, J. V., Smeland, H. Y., Canale, A., Louis, T., Stuhr, L. E. B., Sounni, N. E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125890 · Cited by 148 · see citing works

The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited

Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146 · see citing works

The harsh microenvironment in early breast cancer selects for a Warburg phenotype

Damaghi, M., West, J., Robertson‐Tessi, M., Xu, L., Ferrall‐Fairbanks, M. C., Stewart, P. A., Persi, E., Fridley, B. L., Altrock, P. M., Gatenby, R. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011342118 · Cited by 143 · see citing works

Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance

Saha, T., & Lukong, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856974 · Cited by 147 · see citing works

Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression

Gu, X., Zhu, Y., Su, J., Wang, S., Su, X., Ding, X., Jiang, L., Fei, X., & Zhang, W. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103209 · Cited by 127 · see citing works

Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

Wong, H. Y., Sheng, Q., Hesterberg, A. B., Croessmann, S., Rios, B. L., Giri, K. R., Jackson, J., Miranda, A. X., Watkins, E., Schaffer, K. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33780-1 · Cited by 124 · see citing works

Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment

Xiang, X., Niu, Y., Wang, Z.-H., Ye, L., Peng, W., & Zhou, Q. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.07.006 · Cited by 120 · see citing works

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

Jurj, A. M., Ionescu, C., Berindan‐Neagoe, I., & Braicu, C. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02484-1 · Cited by 109 · see citing works

Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging

Peltier, A., Seban, R., Buvat, I., Bidard, F., & Mechta‐Grigoriou, F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.008 · Cited by 97 · see citing works

Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment

Kim, I., Choi, S., Yoo, S., Lee, M., & Kim, I. (2022) · Cancers · doi:10.3390/cancers14143321 · Cited by 98 · see citing works

The oncogenic role of Jagged1/Notch signaling in cancer

Xiu, M., Liu, Y., & Kuang, B. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110416 · Cited by 93 · see citing works

IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment

Duan, M., Liu, H., Xu, S., Yang, Z., Zhang, F., Wang, G., Wang, Y., Zhao, S., & Jiang, X. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.017 · Cited by 88 · see citing works

Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling

Chen, P., Wei, W.-F., Wu, H.-Z., Fan, L., & Wang, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671595 · Cited by 78 · see citing works

miR-200 deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblastsPreprint

Xue, B., Chuang, C.-H., Prosser, H. M., Fuziwara, C. S., Chan, C., Sahasrabudhe, N. S., Kühn, M., Wu, Y., Chen, J., Biton, A., et al. (2021) · Genes & Development · doi:10.1101/gad.347344.120 · Cited by 73 · see citing works

A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer

Bonneau, C., Eliès, A., Kieffer, Y., Bourachot, B., Ladoire, S., Pelon, F., Héquet, D., Guinebretière, J. M., Blanchet, C., Vincent‐Salomon, A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01311-9 · Cited by 70 · see citing works

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome

Mezheyeuski, A., Segersten, U., Leiss, L. W., Malmström, P., Hatina, J., Östman, A., & Strell, C. (2020) · Scientific Reports · doi:10.1038/s41598-019-55013-0 · Cited by 69 · see citing works

Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets

Lappano, R., Rigiracciolo, D. C., Belfiore, A., Maggiolini, M., & Francesco, E. M. D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1751819 · Cited by 69 · see citing works

Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes

Baker, A. T., Abuwarwar, M. H., Poly, L., Wilkins, S., & Fletcher, A. L. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001203 · Cited by 68 · see citing works

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Micke, P., Strell, C., Mattsson, J. S. M., Martín-Bernabé, A., Brunnström, H., Huvila, J. K., Sund, M., Wärnberg, F., Pontén, F., Glimelius, B. L. G., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103269 · Cited by 65 · see citing works

The role of cancer-associated fibroblasts and exosomal miRNAs-mediated intercellular communication in the tumor microenvironment and the biology of carcinogenesis: a systematic review

Nedaeinia, R., Najafgholian, S., Salehi, R., Goli, M., Ranjbar, M., Nickho, H., Javanmard, S. H., Ferns, G. A., & Manian, M. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02146-5 · Cited by 65 · see citing works

The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis

Yu, S., Wang, S., Wang, X., & Xu, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03518-8 · Cited by 65 · see citing works

Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight

Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 60 · see citing works

Roles of Notch Signaling in the Tumor Microenvironment

D’Assoro, A. B., Leon-Ferre, R. A., Braune, E.-B., & Lendahl, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116241 · Cited by 62 · see citing works

Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer

Venning, F. A., Zornhagen, K. W., Wullkopf, L., Sjölund, J., Rodriguez-Cupello, C., Kjellman, P., Morsing, M., Hajkarim, M. C., Won, K., Erler, J. T., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01944-4 · Cited by 58 · see citing works

The role of Hedgehog and Notch signaling pathway in cancer

Xia, R., Xu, M., Yang, J., & Ma, X. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00099-8 · Cited by 57 · see citing works

Notch signaling in cancer: Complexity and challenges on the path to clinical translation

Ferreira, A. P. A., & Aster, J. C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.008 · Cited by 55 · see citing works

Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer

Owen, J. S., Clayton, A., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom13010067 · Cited by 57 · see citing works

Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells

Gao, D., Fang, L., Liu, C., Yang, M., Yu, X., Wang, L., Zhang, W., Sun, C., & Zhuang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115622 · Cited by 53 · see citing works

CircRNAs regulate the crosstalk between inflammation and tumorigenesis: The bilateral association and molecular mechanisms

Qadir, J., Wen, S.-Y., Yuan, H., & Yang, B. B. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.12.005 · Cited by 51 · see citing works

Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective

Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 50 · see citing works

Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues

Elwakeel, E., & Weigert, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111636 · Cited by 48 · see citing works

Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer

Zou, R., Jiang, Q., Jin, T., Chen, M., Yao, L., & Ding, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956224 · Cited by 44 · see citing works

A review concerning the breast cancer-related tumour microenvironment

Rodríguez-Bejarano, O. H., Parra-López, C., & Patarroyo, M. A. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104389 · Cited by 41 · see citing works

Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies

Mancini, S. J. C., Balabanian, K., Corre, I., Gavard, J., Lazennec, G., Bousse‐Kerdilès, M. L., Louache, F., Maguer‐Satta, V., Mazure, N. M., Mechta‐Grigoriou, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766275 · Cited by 41 · see citing works

The role of cancer-associated fibroblasts in breast cancer metastasis

Li, Y., Wang, C., Huang, T. H., Yu, X., & Tian, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1194835 · Cited by 40 · see citing works

CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer

Magagna, I., Gourdin, N., Kieffer, Y., Licaj, M., Mhaidly, R., André, P., Morel, A., Vincent‐Salomon, A., Paturel, C., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13235878 · Cited by 40 · see citing works

Tumour Microenvironment-Immune Cell Interactions Influencing Breast Cancer Heterogeneity and Disease Progression

Tan, K., & Naylor, M. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.876451 · Cited by 38 · see citing works

Unmasking carcinoma-associated fibroblasts: Key transformation player within the tumor microenvironment

Meng, Q., Luo, X., Chen, J., Wang, D., Chen, E., Zhang, W., Zhang, G., Zhou, W., Xu, J., & Song, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188443 · Cited by 38 · see citing works

Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives

Toledo, B., Picon‐Ruiz, M., Marchal, J. A., & Perán, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415576 · Cited by 39 · see citing works

The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer

Huang, J., Tsang, W. Y., Li, Z., & Guan, X. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.07.001 · Cited by 40 · see citing works

Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment

Zhang, X., Zhu, R., Yu, D., Wang, J., Yan, Y., & Xu, K. (2023) · Cell Proliferation · doi:10.1111/cpr.13592 · Cited by 34 · see citing works

Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma Growth but Promotes Metastasis

Elwakeel, E., Brüggemann, M., Wagih, J., Lityagina, O., Elewa, M. A. F., Han, Y., Frömel, T., Popp, R., Nicolas, A. M., Schreiber, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2116 · Cited by 32 · see citing works

CD36 and CD97 in Pancreatic Cancer versus Other Malignancies

Tănase, C., Gheorghișan-Gălățeanu, A.-A., Popescu, I. D., Mihai, S., Codrici, E., Albulescu, R., & Hinescu, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165656 · Cited by 32 · see citing works

Everybody needs good neighbours: the progressive DCIS microenvironment

Gibson, S. V., Roozitalab, R., Allen, M. D., Jones, J. L., Carter, E. P., & Grose, R. P. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.01.002 · Cited by 31 · see citing works

Functional and clinical roles of stromal PDGF receptors in tumor biology

Strell, C., Rodríguez‐Tomàs, E., & Östman, A. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10194-7 · Cited by 31 · see citing works

Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer

Yan, D., Ju, X., Luo, B., Guan, F., He, H., Yan, H., & Yuan, J. (2022) · BMC Cancer · doi:10.1186/s12885-022-10183-5 · Cited by 30 · see citing works

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC

Kilvaer, T. K., Rakaee, M., Hellevik, T., Vik, J., Petris, L. D., Dønnem, T., Strell, C., Östman, A., Busund, L., & Martínez-Zubiaurre, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-46510-3 · Cited by 30 · see citing works

Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer

Plundrich, D., Chikhladze, S., Fichtner‐Feigl, S., Feuerstein, R., & Briquez, P. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052782 · Cited by 31 · see citing works

Microfluidic-based human prostate-cancer-on-chip

Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T. A., Miranti, C. K., & Zohar, Y. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1302223 · Cited by 26 · see citing works

Unlocking antitumor immunity with adenosine receptor blockers

Remley, V. A., Linden, J. M., Bauer, T. W., & Dimastromatteo, J. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.63 · Cited by 26 · see citing works

Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies

Trnkova, L., Buociková, V., Mego, M., Čumová, A., Buríková, M., Boháč, M., Miklikova, S., Cihova, M., & Smolková, B. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116559 · Cited by 28 · see citing works

Cancer-associated fibroblasts of colorectal cancer and their markers: updates, challenges and translational outlook

Musa, M., & Ali, A. (2020) · Future Oncology · doi:10.2217/fon-2020-0384 · Cited by 25 · see citing works

Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial

Schiza, A., Thurfjell, V., Tullberg, A. S., Olofsson, H., Lindberg, A., Holmberg, E. C., Bremer, T. M., Micke, P., Karlsson, P., Wärnberg, F., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.01.016 · Cited by 23 · see citing works

Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial

Strell, C., Tullberg, A. S., Edelmann, R. J., Akslen, L. A., Malmström, P., Fernö, M., Holmberg, E. C., Östman, A., & Karlsson, P. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06136-4 · Cited by 22 · see citing works

Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment

Samuels, M., Cilibrasi, C., Papanastasopoulos, P., & Giamas, G. (2022) · Biomolecules · doi:10.3390/biom12010132 · Cited by 21 · see citing works

Cancer-associated fibroblasts in carcinogenesis

Zhou, S., Zhao, Z., Wang, Z., Xu, H., Li, Y., Xu, K., Li, W., & Yang, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06071-8 · Cited by 21 · see citing works

Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma

Arebro, J., Lee, C.-M., Bennewith, K. L., & Garnis, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021300 · Cited by 21 · see citing works

Fibroblasts in cancer: Defining target structures for therapeutic intervention

Boesch, M., Baty, F., Rumpold, H. F., Sopper, S., Wolf, D. G. F., & Brutsche, M. H. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.06.003 · Cited by 20 · see citing works

Phenotype transition of fibroblasts incorporated into patient‐derived oral carcinoma organoids

Chen, X., Li, R., Zhao, H., Wang, X., Shao, Z., & Shang, Z. (2021) · Oral Diseases · doi:10.1111/odi.14071 · Cited by 19 · see citing works

Ephrin B Activate Src Family Kinases in Fibroblasts Inducing Stromal Remodeling in Prostate Cancer

Kakarla, M., ChallaSivaKanaka, S., Dufficy, M. F., Gil, V., Filipovich, Y., Vickman, R. E., Crawford, S. E., Hayward, S. W., & Franco, O. E. (2022) · Cancers · doi:10.3390/cancers14092336 · Cited by 19 · see citing works

Tumor-derived miR-130b-3p induces cancer-associated fibroblast activation by targeting SPIN90 in luminal A breast cancer

Ahn, S., Kwon, A., Huh, Y. H., Rhee, S., & Song, W. K. (2022) · Oncogenesis · doi:10.1038/s41389-022-00422-6 · Cited by 19 · see citing works

Mesenchymal stem cells derived from adipose tissue accelerate the progression of colon cancer by inducing a MTCAF phenotype via ICAM1/STAT3/AKT axis

Xue, C., Gao, Y., Sun, Z., Li, X., Zhang, M., Yang, Y., Han, Q., Bai, C., & Zhao, R. C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837781 · Cited by 18 · see citing works

A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer

Burley, A., Rullan, A., & Wilkins, A. C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000888 · Cited by 18 · see citing works

Single cell imaging-based chromatin biomarkers for tumor progression

Venkatachalapathy, S., Jokhun, D. S., Andhari, M. D., & Shivashankar, G. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-02441-6 · Cited by 17 · see citing works

Role of autophagy in cancer-associated fibroblast activation, signaling and metabolic reprograming

Sari, D., Gözüaçık, D., & Akkoç, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1274682 · Cited by 17 · see citing works

Research progress on mechanisms of tumor immune microenvironment and gastrointestinal resistance to immunotherapy: mini review

Zhang, Z., & Wu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1641518 · Cited by 16 · see citing works

Spatial Resolution of Mycobacterium tuberculosis Bacteria and Their Surrounding Immune Environments Based on Selected Key Transcripts in Mouse Lungs

Magoulopoulou, A., Qian, X., Setiabudiawan, T. P., Salas, S. M., Yokota, C., Rottenberg, M. E., Nilsson, M. F., & Carow, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876321 · Cited by 15 · see citing works

From ductal carcinoma in situ to invasive breast cancer: the prognostic value of the extracellular microenvironment

Hulahan, T. S., & Angel, P. M. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03236-z · Cited by 16 · see citing works

Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma

Zhang, X., Bi, X., Liu, P., Liu, Z.-L., Nie, M., Yang, H., Lei, D., Xia, Y., Jiang, W., & Zeng, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01360 · Cited by 16 · see citing works

High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial

Strell, C., Folkvaljon, D., Holmberg, E. C., Schiza, A., Thurfjell, V., Karlsson, P., Bergh, J. C. S., Bremer, T. M., Akslen, L. A., Wärnberg, F., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4300 · Cited by 16 · see citing works

Identifying recurrences and metastasis after ductal carcinoma in situ ( DCIS ) of the breast

Udayasiri, R. I., Luo, T., Gorringe, K. L., & Fox, S. B. (2022) · Histopathology · doi:10.1111/his.14804 · Cited by 16 · see citing works

The infantile myofibromatosis NOTCH3 L1519P mutation leads to hyperactivated ligand-independent Notch signaling and increased PDGFRB expression

Wu, D., Wang, S., Oliveira, D. V., Gaudio, F. D., Vanlandewijck, M., Lebouvier, T., Betsholtz, C., Zhao, J., Jin, S., Lendahl, U., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.046300 · Cited by 16 · see citing works

Heterocellular Adhesion in Cancer Invasion and Metastasis: Interactions between Cancer Cells and Cancer-Associated Fibroblasts

Yamaguchi, H., & Miyazaki, M. (2024) · Cancers · doi:10.3390/cancers16091636 · Cited by 15 · see citing works

Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response

Xiao, Y., Wang, Z., Gu, M., Wei, P., Wang, X., & Li, W. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01375-3 · Cited by 15 · see citing works

Single-cell RNA Sequencing Analysis Reveals the Role of Cancerassociated Fibroblasts in Skin Melanoma

Lian, W., Xiang, P., Ye, C., & Xiong, J. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673282799231211113347 · Cited by 14 · see citing works

A Simple Framework for Agent-Based Modeling with Extracellular Matrix

Metzcar, J., Duggan, B. S., Fischer, B., Murphy, M., Heiland, R. W., & Macklin, P. (2025) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01408-8 · Cited by 14 · see citing works

Metastasis and cancer associated fibroblasts: taking it up a NOTCH

Ghosh, A., & Mitra, A. K. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1277076 · Cited by 12 · see citing works

Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents

Fouillet, J., Torchio, J., Rubira, L., & Fersing, C. (2024) · Biology · doi:10.3390/biology13120967 · Cited by 12 · see citing works

Crosstalk between Prostate Cancer Cells and Tumor-Associated Fibroblasts Enhances the Malignancy by Inhibiting the Tumor Suppressor PLZF

Noh, K. H., Jeong, A. J., Lee, H., Lee, S. H., Yi, E. S., Chang, P., Kwak, C. H., & Ye, S. K. (2020) · Cancers · doi:10.3390/cancers12051083 · Cited by 12 · see citing works

The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis

Cui, M., Dong, H., Duan, W., Wang, X., Liu, Y., Shi, L., & Zhang, B. (2024) · PeerJ · doi:10.7717/peerj.16958 · Cited by 11 · see citing works

A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation

Mega, A., Mebrahtu, A., Aniander, G., Ryer, E., Sköld, A. E., Sandegren, A., Rydin, E. B., Rockberg, J., Östman, A., & Frejd, F. Y. (2023) · mAbs · doi:10.1080/19420862.2023.2223750 · Cited by 11 · see citing works

Cancer-associated fibroblast-derived fibulin-5 promotes epithelial–mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosis

Choi, J., Kwak, Y., Park, M., Jo, J. Y., Kang, J. H., Kook, M., Kim, H., Kim, G., Kong, S., Park, D. J., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01447-8 · Cited by 10 · see citing works

Cell-cell interactions that drive tumorigenesis in Drosophila

Enomoto, M., & Igaki, T. (2022) · Fly · doi:10.1080/19336934.2022.2148828 · Cited by 9 · see citing works

Fibrous Matrix Architecture-Dependent Activation of Fibroblasts with a Cancer-Associated Fibroblast-like Phenotype

Devarasou, S., Kang, M., Kwon, T. Y., Cho, Y., & Shin, J. H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00694 · Cited by 10 · see citing works

Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study

Thennavan, A., García‐Recio, S., Liu, S., He, X., & Perou, C. M. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00450-w · Cited by 9 · see citing works

TGF-β controls stromal telomere length through epigenetic modifications

Mishra, R., Haldar, S., Biondi, S., Bhari, V. K., Singh, G., & Bhowmick, N. A. (2022) · 3 Biotech · doi:10.1007/s13205-022-03346-5 · Cited by 9 · see citing works

The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary system

Hong, R., Yu, P., Zhang, X., Su, P. C., Liang, H., Dong, D. F., Wang, X., & Wang, K. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70299 · Cited by 8 · see citing works

Identification of a Notch transcriptomic signature for breast cancer

Braune, E.-B., Geist, F., Tang, X., Kalari, K. R., Boughey, J. C., Wang, L., Leon-Ferre, R. A., D’Assoro, A. B., Ingle, J. N., Goetz, M. P., et al. (2024) · Breast Cancer Research · doi:10.1186/s13058-023-01757-7 · Cited by 8 · see citing works

Jagged1 regulates extracellular matrix deposition and remodeling in triple-negative breast cancer

Parikainen, M., Suwal, U., Rappu, P., Heino, J., & Sahlgren, C. (2026) · Science Advances · doi:10.1126/sciadv.aea9562 · Cited by 10 · see citing works

Abstract B41: Cell-contact dependent epithelial-stromal cross talk, including a modulation of stromal PDGFR expression, drives the progression of early-stage breast cancer lesions

Strell, C., Paulsson, J., Mezheyeuski, A., Jin, S., Roswall, P., Johanna, A., Frings, O., Warnberg, F., Johansson, H., Jirström, K., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.tme16-b41

Abstract A28: Role of PDGF signaling during the progression of breast ductal carcinoma in situ to invasive carcinoma

Strell, C., Paulsson, J., Wärnberg, F., Johansson, H., Jirström, K., Hall, P. N., & Östman, A. (2013) · Cancer Research · doi:10.1158/1538-7445.tim2013-a28

Abstract P6-10-24: High stromal platelet derived growth factor receptor beta predicts absence of benefit of radiotherapy after breast conserving surgery in breast ductal carcinoma in situ within the SweDCIS randomized trial

Strell, C., Folkvaljon, D., Holmberg, E. C., Karlsson, P., Bergh, J. C. S., Bremer, T. M., Akslen, L. A., Wärnberg, F., & Östman, A. (2020) · Cancer Research · doi:10.1158/1538-7445.sabcs19-p6-10-24

Compartment-specific expression of PDGFR-α and PDGFR-β reveals distinct clinicopathological significance in invasive breast cancerPreprint

Lee, J., Oh, H. K., Lee, N.-R., & Jeong, Y. J. (2026) · Research Square · doi:10.21203/rs.3.rs-10362813/v1

Abstract LB-501: Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ

Casbas-Hernández, P., Troester, M. A., Perez, E. R., Sandhu, R., Kirk, E. L., D’Arcy, M. E., & Rein, J. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-lb-501 · Cited by 2 · see citing works